Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2008, p. 915-919, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01028-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Sciences and Biomedical Technologies, University of L'Aquila, L'Aquila,1 Department of Molecular Biology, University of Siena, Siena,2 Laboratory of Microbiology, University of Catania, Catania, Italy3
Received 6 August 2007/ Returned for modification 8 October 2007/ Accepted 14 December 2007
The aim of this study was to characterize a novel extended-spectrum β-lactamase that belongs to the TEM family, the TEM-149 enzyme, and that was isolated from the urine of two hospitalized patients from different hospitals in southern Italy. The peculiarity of this enzyme was the finding of a valine residue at position 240. The array of amino acid substitutions found in TEM-149 was as follows: E104K, R164S, M182T, and E240V. A reversion of a threonine residue at position 182 was also performed to create a new mutant, TEM-149T182M, in order to assess the contribution of this substitution on the kinetic profile and the stability of TEM-149. The blaTEM-149 and blaTEM-149/T182M genes were cloned into pBC-SK, and the corresponding enzymes were purified from recombinant Escherichia coli HB101 by the same procedure. Both enzymes hydrolyzed all β-lactams tested, with a preference for ceftazidime, which was found to be the best substrate. By comparison of the kinetic parameters of the TEM-149 and the TEM-149T182M enzymes, a reduction of the catalytic efficiency for the TEM-149T182M mutant was observed against all substrates tested except benzylpenicillin, cefotaxime, and aztreonam. Tazobactam, clavulanic acid, and sulbactam were good inhibitors of the TEM-149 β-lactamase.
Published ahead of print on 26 December 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»